133 related articles for article (PubMed ID: 2070279)
1. Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II.
Gram J; Antonsen S; Hørder M; Bollerslev J
Calcif Tissue Int; 1991 Jun; 48(6):438-9. PubMed ID: 2070279
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II--a family study.
Yoneyama T; Fowler HL; Pendleton JW; Sforza PP; Gerard RD; Lui CY; Eldridge TH; Iranmanesh A
Clin Genet; 1992 Jul; 42(1):39-42. PubMed ID: 1516225
[TBL] [Abstract][Full Text] [Related]
3. Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers.
Waguespack SG; Hui SL; White KE; Buckwalter KA; Econs MJ
J Clin Endocrinol Metab; 2002 May; 87(5):2212-7. PubMed ID: 11994366
[TBL] [Abstract][Full Text] [Related]
4. Serum creatine kinase isoenzyme BB in mammalian osteopetrosis.
Bollerslev J; Ueland T; Landaas S; Marks SC
Clin Orthop Relat Res; 2000 Aug; (377):241-7. PubMed ID: 10943208
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and laboratory evaluation of a type II autosomal dominant osteopetrosis carrier.
Takacs I; Cooper H; Weaver DD; Econs MJ
Am J Med Genet; 1999 Jul; 85(1):9-12. PubMed ID: 10377007
[TBL] [Abstract][Full Text] [Related]
6. Creatine kinase brain isoenzyme in infantile osteopetrosis.
Hiroyama Y; Miike T; Sugino S; Taku K
Pediatr Neurol; 1987; 3(1):54-7. PubMed ID: 3508049
[TBL] [Abstract][Full Text] [Related]
7. Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders.
Whyte MP; Chines A; Silva DP; Landt Y; Ladenson JH
J Bone Miner Res; 1996 Oct; 11(10):1438-43. PubMed ID: 8889843
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Schönberg disease (Chloride Channel 7 Deficiency Osteopetrosis) among the sclerosing bone disorders.
Whyte MP; Kempa LG; McAlister WH; Zhang F; Mumm S; Wenkert D
J Bone Miner Res; 2010 Nov; 25(11):2515-26. PubMed ID: 20499337
[TBL] [Abstract][Full Text] [Related]
9. The role of carbonic anhydrase in autosomal dominant osteopetrosis.
Bollerslev J; Mondrup MP
Scand J Clin Lab Invest; 1989 Feb; 49(1):93-5. PubMed ID: 2499032
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for genetic heterogeneity within type II autosomal dominant osteopetrosis.
Bénichou OD; Bénichou B; Copin H; De Vernejoul MC; Van Hul W
J Bone Miner Res; 2000 Oct; 15(10):1900-4. PubMed ID: 11028441
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of creatine kinase BB isoenzyme in three patients with adult osteopetrosis.
Yoneyama T; Fowler HL; Pendleton JW; Sforza PP; Lui CY; Iranmanesh A; Gerard RD
N Engl J Med; 1989 May; 320(19):1284-5. PubMed ID: 2710212
[No Abstract] [Full Text] [Related]
12. Elevated serum CK-MB and CK-BB isoenzymes in a patient with small cell lung cancer: a case report.
Wang HC; Lu JY; Ting YM
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Mar; 55(3):270-3. PubMed ID: 7780887
[TBL] [Abstract][Full Text] [Related]
13. Type II autosomal dominant osteopetrosis.
Senel K; Ugur M; Erdal A; Ozdemir H
Rheumatol Int; 2002 Jul; 22(3):116-8. PubMed ID: 12111087
[TBL] [Abstract][Full Text] [Related]
14. Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3.
Bénichou O; Cleiren E; Gram J; Bollerslev J; de Vernejoul MC; Van Hul W
Am J Hum Genet; 2001 Sep; 69(3):647-54. PubMed ID: 11468688
[TBL] [Abstract][Full Text] [Related]
15. Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients.
Bénichou OD; Laredo JD; de Vernejoul MC
Bone; 2000 Jan; 26(1):87-93. PubMed ID: 10617161
[TBL] [Abstract][Full Text] [Related]
16. [A case of osteopetrosis with an abnormal CK-MB/T-CK ratio].
Ito K; Komiyama Y; Mitani K; Ogawa N; Egawa H; Takahashi H
Rinsho Byori; 1997 Dec; 45(12):1197-200. PubMed ID: 9437904
[TBL] [Abstract][Full Text] [Related]
17. Cortical bone remodeling in autosomal dominant osteopetrosis: a study of two different phenotypes.
Brockstedt H; Bollerslev J; Melsen F; Mosekilde L
Bone; 1996 Jan; 18(1):67-72. PubMed ID: 8717539
[TBL] [Abstract][Full Text] [Related]
18. The presence of creatine kinase BB isoenzyme in patients with prostatic cancer.
Feld RD; van Steirteghem AC; Zweig MH; Weimar GW; Narayana AS; Witte DL
Clin Chim Acta; 1980 Jan; 100(3):267-73. PubMed ID: 7353312
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of serum creatine kinase isoenzyme BB in patients with malignancies.
Abbott LB; Lott JA
Clin Chem; 1984 Nov; 30(11):1861-3. PubMed ID: 6435914
[TBL] [Abstract][Full Text] [Related]
20. Creatine kinase isoenzyme (CK-BB) by RIA as a follow-up marker in stage D cancer of the prostate: comparison with PAP RIA.
El-Shribiny A; Bharvaga A; Fitzpatrick J; Murphy GP
J Surg Oncol; 1985 Mar; 28(3):232-6. PubMed ID: 3974250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
